MAGic™ Beads Protein G offer one-step clarification and capture of monoclonal antibodies, which do not have an affinity towards Protein A. It eliminates the need for centrifugation, depth filtration and Protein G affinity column-chromatography. Super-paramagnetic porous beads coupled with a Protein G ligand.
ABISORB-DC is a co-processed excipient system for the direct compression tablet manufacturing of self-emulsifying drug delivery systems and other pharmaceutical oils.
The Gyrolab® Mouse IFN-gamma Kit enables rapid quantification of murine IFN-gamma in serum samples
Our Comprehensive In Vitro Proarrhythmia Assay (CiPA) service assesses proarrhythmic potential of compounds beyond hERG inhibition, integrating effects on multiple cardiac ion channels and human iPSC-derived cardiomyocytes via patch clamp and multi-well MEA platforms. Aligned with FDA's CiPA initiative and ICH E14/S7B guidelines, it predicts QT prolongation and TdP risks for enhanced specificity in early drug safety evaluation…
Machine-learning software that reduces the analysis bottleneck of large data sets in your surface plasmon resonance workflow
FITC-Labeled Human GPRC5D Full Length Protein, Flag,His Tag (GPD-HF2D6) is expressed from human 293 cells (HEK293). This protein carries a Flag tag at the N-terminus and a polyhistidine tag at the C-terminus. The protein has a calculated MW of 37.9 kDa.
Syngeneic urothelial carcinoma model for bladder cancer research and immunotherapy development
Screen for high-producing, viable clones—faster and with greater confidence
Human Claudin-18.2 Full Length Protein-VLP (CL2-H52P7) is expressed from human 293 cells (HEK293). Virus-like particles(VLPs) are formed by self-assembly of envelop/capsid proteins from viruses. Membrane Proteins can be constituted in-situ with VLPs produced from HEK293 cell cultures.
Human VEGF165, His Tag (VE5-H5248) is expressed from human 293 cells (HEK293). It carries a polyhistidine tag at the N-terminus, and has a calculated MW of 21.1 kDa. The protein migrates as 27-28 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Stable Isotope-labeled Products for Drug Screening and Analysis
The Rexxip™ Scouting Pack enables screening of buffers for assay optimisation
ISOAPI-D™: Built Specifically for the Next Generation of Deuterated Reagents in Pharmaceutical Development
Simplify synthesis and scale-up of potent mRNA with third-generation CleanCap®—proven technology for enhanced in vivo translatability.
Our Protein Binding Platform assesses drug-protein interactions using equilibrium dialysis and ultracentrifugation methods to determine unbound fractions and distribution in biological samples including plasma, blood, tissues, and cells. This essential ADME service evaluates reversible drug transfer between compartments, providing insights into pharmacokinetics, bioavailability, and potential interactions.
MAGic™ Beads Protein A offer one-step clarification and capture of monoclonal antibodies, eliminating the need for centrifugation, depth filtration and Protein A affinity column-chromatography. Super-paramagnetic porous beads coupled with an alkali resistant Protein A ligand.
Myelotracker® is a cutting-edge fluorescent probe that enables precise detection of neutrophils—essential immune cells—in both blood and tissue samples. It offers researchers a dependable tool for exploring inflammation, infections, and immune system activity.
A sensitive and robust assay to easily detect mouse IgG antibodies in picodroplets.
Pion’s PAMPA high-throughput permeability assay uses a range of membranes to mimic physiologic conditions. It allows you to evaluate the passive permeability of API’s as well as the absorption potential of simple or complex formulations using robust models and protocols in a 96-well format.
Sf9 HCP 3G Solution for Gyrolab for the detection of Sf9 host cell protein impurities in bioprocess samples.
E.Coli HCP 2G Solution for Gyrolab enables detection of E. coli HCP impurities in products manufactured by recombinant expression.
Our hERG Safety Screening service employs the Synchropatch-384 automated patch clamp system to assess compound effects on the hERG potassium channel. This high-throughput assay detects inhibitors that may prolong QT intervals and cause arrhythmias, aiding early drug safety evaluation. With precise data under physiological conditions, it supports regulatory compliance to advance safer therapeutics.
